ID22746A - Senyawa-senyawa baru - Google Patents

Senyawa-senyawa baru

Info

Publication number: ID22746A
Authority: ID; Indonesia
Prior art keywords: pct; date; new compounds; sec; pub
Prior art date: 1997-04-15

Application number

IDW991207A

Other languages

English (en)

Indonesian (id)

Inventor

David Cheshire

Martin Cooper

David Donald

Philip Thorne

Original Assignee

Astra Pharma Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-15

Filing date

1998-04-07

Publication date

1999-12-09

1998-04-07 Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod

1999-12-09 Publication of ID22746A publication Critical patent/ID22746A/id

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

IDW991207A 1997-04-15 1998-04-07 Senyawa-senyawa baru ID22746A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9701398A SE9701398D0 (sv)	1997-04-15	1997-04-15	Novel compounds

Publications (1)

Publication Number	Publication Date
ID22746A true ID22746A (id)	1999-12-09

Family

ID=20406576

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW991207A ID22746A (id)	1997-04-15	1998-04-07	Senyawa-senyawa baru

Country Status (21)

Country	Link
US (1)	US6028074A (no)
EP (1)	EP0975636B1 (no)
JP (1)	JP2001520645A (no)
KR (1)	KR20010006350A (no)
CN (1)	CN1259951A (no)
AT (1)	ATE245648T1 (no)
AU (1)	AU733066B2 (no)
BR (1)	BR9808540A (no)
CA (1)	CA2286078A1 (no)
DE (1)	DE69816608T2 (no)
EE (1)	EE9900465A (no)
HU (1)	HUP0002104A3 (no)
ID (1)	ID22746A (no)
IL (1)	IL132153A0 (no)
IS (1)	IS5198A (no)
NO (1)	NO995006L (no)
PL (1)	PL336230A1 (no)
SE (1)	SE9701398D0 (no)
SK (1)	SK135699A3 (no)
TR (1)	TR199902538T2 (no)
WO (1)	WO1998046606A1 (no)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9801399D0 (sv)	1998-04-21	1998-04-21	Astra Pharma Prod	Method and apparatus for filling containers
GC0000177A (en)	1998-12-17	2006-03-29	Smithkline Beecham	Thrombopoietin mimetics
CY2010012I2 (el)	2000-05-25	2020-05-29	Novartis Ag	Μιμητικα θρομβοποιητινης
JP2004527541A (ja)	2001-03-01	2004-09-09	スミスクライン・ビーチャム・コーポレイション	トロンボポエチン模倣物
JP2005511500A (ja)	2001-08-31	2005-04-28	ザロックフェラーユニバーシティー	脳におけるホスホジエステラーゼ活性およびホスホジエステラーゼ１ｂ媒介シグナル伝達の調節
AR040083A1 (es)	2002-05-22	2005-03-16	Smithkline Beecham Corp	Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac
TW200526638A (en)	2003-10-22	2005-08-16	Smithkline Beecham Corp	2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
US9226885B2 (en) *	2005-05-24	2016-01-05	Allium Vitalis Incorporated	Personal care and medicinal products incorporating bound organosulfur groups
CN101248050B (zh)	2005-06-06	2013-07-17	武田药品工业株式会社	有机化合物
WO2007143705A2 (en) *	2006-06-06	2007-12-13	Intra-Cellular Therapies, Inc.	Organic compounds
ES2411604T3 (es)	2006-11-13	2013-07-05	Intra-Cellular Therapies, Inc.	Compuestos orgánicos
US9006258B2 (en)	2006-12-05	2015-04-14	Intra-Cellular Therapies, Inc.	Method of treating female sexual dysfunction with a PDE1 inhibitor
ECSP077628A (es)	2007-05-03	2008-12-30	Smithkline Beechman Corp	Nueva composición farmacéutica
JP5701608B2 (ja) *	2007-12-06	2015-04-15	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
CA2845454C (en)	2007-12-06	2017-02-07	Takeda Pharmaceutical Company Limited	Organic compounds useful as inhibitors of phosphodiesterase 1
MX2011005934A (es) *	2008-12-06	2011-12-16	Intra Cellular Therapies Inc	Compuestos organicos.
JP5710493B2 (ja)	2008-12-06	2015-04-30	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	有機化合物
MX2011005935A (es)	2008-12-06	2011-12-16	Intra Cellular Therapies Inc	Compuestos organicos.
EA201170771A1 (ru)	2008-12-06	2012-01-30	Интра-Селлулар Терапиз, Инк.	Органические соединения
WO2010065149A1 (en)	2008-12-06	2010-06-10	Intra-Cellular Therapies, Inc.	Organic compounds
SG171774A1 (en)	2008-12-06	2011-07-28	Intra Cellular Therapies Inc	Organic compounds
JP2012518685A (ja)	2009-02-25	2012-08-16	イントラ−セルラー・セラピーズ・インコーポレイテッド	眼障害のためのｐｄｅ１阻害剤
WO2010109328A1 (en)	2009-03-23	2010-09-30	Glenmark Pharmaceuticals, S.A.	Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
PL2411393T3 (pl)	2009-03-23	2014-06-30	Glenmark Pharmaceuticals Sa	Pochodne skondensowanego pirymidynodionu jako modulatory TRPA1
SG174398A1 (en)	2009-03-23	2011-10-28	Glenmark Pharmaceuticals Sa	Furopyrimidinedione derivatives as trpa1 modulators
US8623880B2 (en)	2009-03-23	2014-01-07	Glenmark Pharmaceuticals S.A.	Fused pyrimidine-dione derivatives as TRPA1 modulators
EP2434895A4 (en)	2009-05-13	2013-08-07	Intra Cellular Therapies Inc	ORGANIC CONNECTIONS
JP2012528184A (ja)	2009-05-29	2012-11-12	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー	トロンボポエチンアゴニスト化合物の投与の方法
SG10201507362TA (en)	2009-08-05	2015-10-29	Intra Cellular Therapies Inc	Novel Regulatory Proteins And Inhibitors
US9763948B2 (en)	2010-05-31	2017-09-19	Intra-Cellular Therapies, Inc.	PDE1 inhibitory compounds and methods
US9371327B2 (en)	2010-05-31	2016-06-21	Intra-Cellular Therapies, Inc.	PDE1 inhibitor compounds
WO2011153136A1 (en)	2010-05-31	2011-12-08	Intra-Cellular Therapies, Inc.	Organic compounds
TW201206937A (en)	2010-05-31	2012-02-16	Intra Cellular Therapies Inc	Organic compounds
EP2717877B1 (en)	2011-06-10	2017-11-08	Intra-Cellular Therapies, Inc.	Organic compounds
MY165622A (en)	2012-06-08	2018-04-18	Glenmark Pharmaceuticals Sa	Amides of 2-amino-4aryl thiazole compounds and their salts
EP2956141A4 (en)	2013-02-17	2016-10-26	Intra Cellular Therapies Inc	NEW USES
TWI659032B (zh)	2013-03-15	2019-05-11	美商內胞醫療公司	有機化合物及其用途
US9545406B2 (en)	2013-03-15	2017-01-17	Intra-Cellular Therapies, Inc.	Method of treating a CNS injury with a PDE1 inhibitor
WO2015106032A1 (en)	2014-01-08	2015-07-16	Intra-Cellular Therapies, Inc.	Products and pharmaceutical compositions
WO2015196186A1 (en)	2014-06-20	2015-12-23	Intra-Cellular Therapies, Inc.	Organic compounds
ES2745819T3 (es)	2014-08-07	2020-03-03	Intra Cellular Therapies Inc	Derivados de imidazo[1,2-a]-pirazolo[4,3-e]-pirimidin-4-ona con actividad inhibidora de la PDE1
US9546175B2 (en)	2014-08-07	2017-01-17	Intra-Cellular Therapies, Inc.	Organic compounds
US10285992B2 (en)	2014-08-07	2019-05-14	Intra-Cellular Therapies, Inc.	Combinations of PDE1 inhibitors and NEP inhibitors and associated methods
ES2857567T3 (es)	2014-09-17	2021-09-29	Intra Cellular Therapies Inc	Derivados de 7,8-dihidro-[2h]-imidazo-[1,2-a]pirazolo[4,3-e]pirimidin-4(5h)-ona como inhibidores de fosfodiesterasa 1 (PDE1) para tratar enfermedades, trastornos o lesiones del sistema nervioso central (SNC)
RU2709786C2 (ru)	2014-12-06	2019-12-20	Интра-Селлулар Терапиз, Инк.	Органические соединения
JP6608933B2 (ja)	2014-12-06	2019-11-20	イントラ−セルラー・セラピーズ・インコーポレイテッド	有機化合物
JP2019510039A (ja)	2016-03-28	2019-04-11	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	新規組成物および方法
CN109311886B (zh) *	2016-06-23	2021-11-09	豪夫迈·罗氏有限公司	[1,2,3]***并[4,5-d]嘧啶衍生物
ES2906107T3 (es)	2016-09-12	2022-04-13	Intra Cellular Therapies Inc	Usos novedosos
JP7401442B2 (ja)	2018-01-31	2023-12-19	イントラ－セルラー・セラピーズ・インコーポレイテッド	新規使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0077372A1 (de) *	1981-04-22	1983-04-27	Byk Gulden Lomberg Chemische Fabrik GmbH	NEUE PYRAZOLO(3,4-d)PYRIMIDINE, VERFAHREN ZU DEREN HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL
US4603203A (en) *	1983-12-14	1986-07-29	Takeda Chemical Industries, Ltd.	3-aminopyrazolo[3,4-d]pyrimidine derivatives and production thereof
EP0237289A3 (en) *	1986-03-14	1988-07-27	Takeda Chemical Industries, Ltd.	Pyrazolo [3,4-d] pyrimidine derivatives, their production and use
TW444018B (en) *	1992-12-17	2001-07-01	Pfizer	Pyrazolopyrimidines
NZ257770A (en) *	1992-12-17	1997-02-24	Pfizer	3- acylpyrazole and pyrazolo[3,4-d]pyrimidine derivatives

1997
- 1997-04-15 SE SE9701398A patent/SE9701398D0/xx unknown
1998
- 1998-04-07 KR KR1019997009435A patent/KR20010006350A/ko not_active Application Discontinuation
- 1998-04-07 AT AT98917859T patent/ATE245648T1/de not_active IP Right Cessation
- 1998-04-07 EP EP98917859A patent/EP0975636B1/en not_active Expired - Lifetime
- 1998-04-07 CN CN98806075A patent/CN1259951A/zh active Pending
- 1998-04-07 TR TR1999/02538T patent/TR199902538T2/xx unknown
- 1998-04-07 BR BR9808540-9A patent/BR9808540A/pt not_active IP Right Cessation
- 1998-04-07 SK SK1356-99A patent/SK135699A3/sk unknown
- 1998-04-07 DE DE69816608T patent/DE69816608T2/de not_active Expired - Fee Related
- 1998-04-07 ID IDW991207A patent/ID22746A/id unknown
- 1998-04-07 JP JP54380398A patent/JP2001520645A/ja not_active Ceased
- 1998-04-07 IL IL13215398A patent/IL132153A0/xx unknown
- 1998-04-07 AU AU70909/98A patent/AU733066B2/en not_active Ceased
- 1998-04-07 EE EEP199900465A patent/EE9900465A/xx unknown
- 1998-04-07 WO PCT/SE1998/000640 patent/WO1998046606A1/en active IP Right Grant
- 1998-04-07 PL PL98336230A patent/PL336230A1/xx unknown
- 1998-04-07 HU HU0002104A patent/HUP0002104A3/hu unknown
- 1998-04-07 CA CA002286078A patent/CA2286078A1/en not_active Abandoned
- 1998-08-07 US US09/068,304 patent/US6028074A/en not_active Expired - Fee Related
1999
- 1999-09-27 IS IS5198A patent/IS5198A/is unknown
- 1999-10-14 NO NO995006A patent/NO995006L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR9808540A (pt)	2000-05-23
ATE245648T1 (de)	2003-08-15
PL336230A1 (en)	2000-06-19
NO995006D0 (no)	1999-10-14
CN1259951A (zh)	2000-07-12
CA2286078A1 (en)	1998-10-22
SE9701398D0 (sv)	1997-04-15
DE69816608D1 (de)	2003-08-28
TR199902538T2 (xx)	2000-02-21
EP0975636B1 (en)	2003-07-23
AU7090998A (en)	1998-11-11
EE9900465A (et)	2000-04-17
HUP0002104A3 (en)	2002-03-28
SK135699A3 (en)	2000-05-16
EP0975636A1 (en)	2000-02-02
JP2001520645A (ja)	2001-10-30
KR20010006350A (ko)	2001-01-26
IS5198A (is)	1999-09-27
DE69816608T2 (de)	2004-04-15
IL132153A0 (en)	2001-03-19
AU733066B2 (en)	2001-05-03
US6028074A (en)	2000-02-22
HUP0002104A2 (hu)	2001-01-29
WO1998046606A1 (en)	1998-10-22
NO995006L (no)	1999-10-14

Publication	Publication Date	Title
ID22746A (id)	1999-12-09	Senyawa-senyawa baru
ID25628A (id)	2000-10-19	Senyawa-senyawa baru
ID28432A (id)	2001-05-24	Senyawa-senyawa baru
EE9900315A (et)	2000-02-15	Pürrolo[3,4-d]pürimidinooni derivaadid ja nende kasutamine ravimitena
DE69736441D1 (de)	2006-09-14	Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
HUP0104318A2 (hu)	2002-03-28	cGMP PDE-5 inhibitort tartalmazó szabályzottan hatóanyagot felszabadító gyógyászati készítmények
HK1075450A1 (en)	2005-12-16	heterocyclic compunds, process for their preparation and pharmaceutical compositions containing thenm and thier use in medicine
HUP0002346A1 (hu)	2001-05-28	Emlősök elmezavarainak kezelésére szolgáló gyógyszerkészítmény
ATE251162T1 (de)	2003-10-15	Triazolo(4,5-d)pyrimidin-verbindungen
HUP0100611A2 (hu)	2001-09-28	Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
AU3862997A (en)	1998-02-20	Stable derivatives of ubiquinole, processes for their production and pharmaceutical use thereof
DE69804766T2 (de)	2002-10-10	Isoflavonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AU7436098A (en)	1998-11-13	Use of mizolastine for preparing a medicine for treating inflammation